Pending regulatory approvals, the UBC-Tilray study is poised to be one of the first in the world to run a large-scale clinical trial examining medical cannabis as a treatment for a mental health disorder.
Ireland becomes the 13th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need
Former Nissan North America Vice President Kristina Adamski joins Tilray to lead the company’s global corporate affairs team
Lock-up to be Extended for up to Two Years on 77 Percent of Tilray’s Total Shares Outstanding
Transaction Expected to be Tax-Efficient for Privateer Stockholders
Tilray’s complete product offering now the broadest medical cannabis offering from a Licensed Producer in the market